GV 2021 Gp, LLC, 10% Owner at Prime Medicine, Inc. (PRME), sold 185,097 shares at $13.65 ($1.7M) on 2023-05-31, disclosed to the SEC on 2023-06-02.
Scheduled sale ($1.7M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 16,633 | $0 | 0.0% |
| 2 | $13.65 | 16,633 | $227K | 13.0% |
| 3 | $13.65 | 16,633 | $227K | 13.0% |
| 4 | $0.00 | 45,223 | $0 | 0.0% |
| 5 | $14.35 | 44,752 | $642K | 36.8% |
| 6 | $14.35 | 44,752 |
| $642K |
| 36.8% |
| 7 | $14.75 | 471 | $7K | 0.4% |
| Total | $9.43 avg | 185,097 | $1.7M | 100% |
| Filing → |